Published in Am J Med on July 01, 1983
Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ (2003) 1.03
Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. Br Med J (Clin Res Ed) (1988) 0.80
Refeeding and metabolic syndromes: two sides of the same coin. Nutr Diabetes (2014) 0.79
Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology (1997) 3.68
Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2. Medicine (Baltimore) (1968) 3.14
Renal gluconeogenesis in acidosis, alkalosis, and potassium deficiency: its possible role in regulation of renal ammonia production. J Clin Invest (1966) 2.64
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Mult Scler (2010) 2.30
Frequency of anti-nuclear antibodies in multiple sclerosis. Neurology (1995) 2.07
Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest (1985) 2.00
Time to listen: a review of methods to solicit patient reports of adverse events. Qual Saf Health Care (2010) 1.84
Quantitative functional measures in MS: what is a reliable change? Neurology (2002) 1.81
GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc Natl Acad Sci U S A (1989) 1.73
Skeletal muscle enzymes and fiber composition in male and female track athletes. J Appl Physiol (1976) 1.66
Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS. Neurology (2007) 1.62
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS. Neurology (2002) 1.61
Acid-base alterations and renal gluconeogenesis: effect of pH, bicarbonate concentration, and PCO2. J Clin Invest (1967) 1.55
The gene for Darier's disease maps to chromosome 12q23-q24.1. Hum Mol Genet (1993) 1.47
The effects of alternate exposure to altitude and sea level on world-class middle-distance runners. Med Sci Sports (1970) 1.42
Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour. BJOG (2010) 1.41
A prospective double blind placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder pain. Rheumatology (Oxford) (2007) 1.39
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol (2001) 1.35
Hypernatremia due to hypodipsia and elevated threshold for vasopressin release. Effects of treatment with hydrochlorothiazide, chlorpropamide and tolbutamide. N Engl J Med (1968) 1.26
Relation of renal cortical gluconeogenesis, glutamate content, and production of ammonia. J Clin Invest (1970) 1.24
Elevation of plasma glutamate in gout. Its possible role in the pathogenesis of hyperuricemia. N Engl J Med (1969) 1.21
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium. Mult Scler (2003) 1.16
A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (1998) 1.15
Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. Cancer Treat Rep (1983) 1.14
Effect of metabolic acidosis on renal gluconeogenesis in vivo. Am J Physiol (1968) 1.13
Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis (2001) 1.12
The measurement of ambulatory impairment in multiple sclerosis. Neurology (1997) 1.11
Rapid disease course in African Americans with multiple sclerosis. Neurology (2010) 1.10
Quantitative assessment of motor fatigue and strength in MS. Neurology (1999) 1.08
Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol (1999) 1.06
DNA marker applicable to presymptomatic and prenatal diagnosis of facioscapulohumeral disease. Lancet (1990) 1.04
Effect of adenosine 3',5'-monophosphate on production of glucose and ammonia by renal cortex. J Clin Invest (1969) 1.02
Assessing genetic diversity in plasmids from Escherichia coli and Salmonella enterica using a mixed-plasmid microarray. J Appl Microbiol (2006) 1.02
Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol (1996) 1.00
A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results. J Clin Periodontol (2002) 1.00
Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. Br J Dermatol (2001) 1.00
Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol (2001) 0.99
Are quantitative functional measures more sensitive to worsening MS than traditional measures? Neurology (2000) 0.99
Eikenella corrodens isolated in oral infections of dental origin. Oral Surg Oral Med Oral Pathol (1977) 0.99
Serum immunoglobulin elevations in the acquired immunodeficiency syndrome (AIDS): IgG, IgA, IgM, and IgD. Diagn Immunol (1984) 0.99
Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma. Metabolism (1971) 0.99
Altitude and maximum performance in work and sports activity. JAMA (1965) 0.98
Portable respiratory gas collection equipment. J Appl Physiol (1971) 0.98
Existence of two forms of immunoreactive growth hormone in human plasma. J Clin Endocrinol Metab (1972) 0.97
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. Mult Scler (2010) 0.94
Evidence of association and linkage disequilibrium between a novel polymorphism in the transforming growth factor beta 1 gene and hip bone mineral density: a study of female twins. Rheumatology (Oxford) (2001) 0.94
Conditioning of cyclophosphamide-induced leukopenia in humans. J Neuropsychiatry Clin Neurosci (1996) 0.93
Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy. J Neurovirol (1999) 0.93
Hysterectomy with bilateral salpingo-oophorectomy: a survey of gynecological practice. Acta Obstet Gynecol Scand (2001) 0.92
Linkage studies of bipolar disorder in the region of the Darier's disease gene on chromosome 12q23-24.1. Am J Med Genet (1995) 0.92
A closely linked DNA marker for facioscapulohumeral disease on chromosome 4q. J Med Genet (1991) 0.92
Cervical cerclage and type of suture material: a survey of UK consultants' practice. J Matern Fetal Neonatal Med (2014) 0.92
Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int (1997) 0.92
Cholera toxin partially inhibits the T-cell response to phytohaemagglutinin through the ADP-ribosylation of a 45 kDa membrane protein. Biochem J (1988) 0.91
Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes (1984) 0.89
Capnocytophaga found in root canal system of a nonvital tooth. Oral Surg Oral Med Oral Pathol (1982) 0.89
Pitfalls in the determination of plasma glutamate. N Engl J Med (1968) 0.89
Solitary choroidal mass as the presenting sign in systemic sarcoidosis. Br J Ophthalmol (1983) 0.89
The Percutaneous shunting in Lower Urinary Tract Obstruction (PLUTO) study and randomised controlled trial: evaluation of the effectiveness, cost-effectiveness and acceptability of percutaneous vesicoamniotic shunting for lower urinary tract obstruction. Health Technol Assess (2013) 0.89
Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator. Chest (1991) 0.88
Increasing the efficiency of genomic searches for linkage in complex disorders by DNA pooling of affected sib-pairs. Mol Psychiatry (1996) 0.88
Changes in oxygen consumption of young boys during growth and running training. Med Sci Sports (1971) 0.87
Partial characterization and assignment of the gene for protoporphyrinogen oxidase and variegate porphyria to human chromosome 1q23. Hum Mol Genet (1995) 0.87
Umbilical granulomas: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed (2003) 0.87
Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes. J Biotechnol (2000) 0.87
Physiological characteristics of champion male athletes. Res Q (1974) 0.87
Autonomic neuropathy associated with autoimmune disease. Neurology (1985) 0.87
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data. Mult Scler (2008) 0.86
The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J Clin Virol (2000) 0.86
The nutritional habits of young adolescent swimmers. Int J Sport Nutr (1991) 0.85
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS. Neurology (2009) 0.85
Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: an electron microscopic study. Infect Immun (2000) 0.85
Pathogenesis of Bartter's syndrome. N Engl J Med (1969) 0.85
Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b. Arch Neurol (1997) 0.84
Clinical evaluation of algorithms for context-sensitive physiological monitoring in children. Br J Anaesth (2009) 0.83
Prevalence, extent and severity of severe periodontal destruction in an urban Aboriginal and Torres Strait Islander population. Aust Dent J (2014) 0.83
The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis. Am J Med (1994) 0.83
Effect of 3',5'-GMP and 3',5'-IMP on production of glucose and ammonia by renal cortex. Am J Physiol (1970) 0.83
Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial. Mult Scler (2003) 0.83
No association between general cognitive ability and the A1 allele of the D2 dopamine receptor gene. Behav Genet (1997) 0.82
Ruptured intracranial aneurysms during pregnancy. A report of four cases. J Reprod Med (1986) 0.82
An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis. Mult Scler (2004) 0.82
No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. Am J Med Genet (1995) 0.82
Studies of the composition and radioreceptor activity of "big" and "little" human growth hormone. J Clin Endocrinol Metab (1977) 0.82
Aerobic responses of female distance runners to submaximal and maximal exercise. Ann N Y Acad Sci (1977) 0.81
Rapid onset of severe retinopathy, cataracts and neuropathy in young patients with diabetes mellitus. Acta Paediatr (1992) 0.80
Lectin-binding to hemocytes of Mytilus edulis. Dev Comp Immunol (1985) 0.80
Barnacle reattachment: a tool for studying barnacle adhesion. Biofouling (2008) 0.79
Letter: Saltiness of "Morton Lite-Salt" and table salt used with rice. N Engl J Med (1976) 0.79
Liver hemorrhage during laparotomy in patients with necrotizing enterocolitis. J Pediatr Surg (1996) 0.79
Multidisciplinary preoperative assessment and late function in dysvascular amputees. Clin Orthop Relat Res (1992) 0.79
Studies on "big" growth hormone from human plasma and pituitary. J Clin Invest (1974) 0.79
Human herpesvirus 6-meningoencephalitis in an HIV patient with progressive multifocal leukoencephalopathy. Acta Neuropathol (2000) 0.79
Differences and changes in VO2 among young runners 10 to 18 years of age. Med Sci Sports (1978) 0.79
Clinical diagnosis of multiple sclerosis. The impact of magnetic resonance imaging and ancillary testing. Rochester-Toronto Magnetic Resonance Study Group. Arch Neurol (1994) 0.78
Deficiency of the seventh component of complement. A case report. S Afr Med J (1991) 0.78
Interval training and performance. Sports Med (1985) 0.78
Alcohol screening and brief intervention: where research meets practice. Conn Med (1997) 0.78
Clinical trials with thymosin. Ann N Y Acad Sci (1979) 0.78
Isolation and amplification of human IgE Fd encoding mRNA from human peripheral blood lymphocytes. J Immunol Methods (1992) 0.78